Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nuvilex Net Income 2010-2025 | PMCB

Nuvilex net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Nuvilex Annual Net Income
(Millions of US $)
2024 $-17
2023 $-4
2022 $-4
2021 $-4
2020 $-4
2019 $-4
2018 $-7
2017 $-4
2016 $-6
2015 $-10
2014 $-27
2013 $-2
2012 $-2
2011 $-1
2010 $-6
2009 $-6
Nuvilex Quarterly Net Income
(Millions of US $)
2025-01-31 $-3
2024-10-31 $-3
2024-07-31 $15
2024-04-30 $-3
2024-01-31 $-6
2023-10-31 $-2
2023-07-31 $-7
2023-04-30 $0
2023-01-31 $-1
2022-10-31 $-2
2022-07-31 $-2
2022-04-30 $-1
2022-01-31 $-1
2021-10-31 $-1
2021-07-31 $-1
2021-04-30 $-1
2021-01-31 $-1
2020-10-31 $-1
2020-07-31 $-1
2020-04-30 $-1
2020-01-31 $-1
2019-10-31 $-1
2019-07-31 $-1
2019-04-30 $-1
2019-01-31 $-1
2018-10-31 $-1
2018-07-31 $-1
2018-04-30 $-1
2018-01-31 $-2
2017-10-31 $-2
2017-07-31 $-2
2017-04-30 $-1
2017-01-31 $-1
2016-10-31 $-1
2016-07-31 $-1
2016-04-30 $-1
2016-01-31 $-2
2015-10-31 $-2
2015-07-31 $-2
2015-04-30 $-3
2015-01-31 $-1
2014-10-31 $-4
2014-07-31 $-2
2014-04-30 $-16
2014-01-31 $0
2013-10-31 $-6
2013-07-31 $-5
2013-04-30 $0
2013-01-31 $0
2012-10-31 $0
2012-07-31 $-1
2012-04-30 $-1
2012-01-31 $0
2011-10-31 $0
2011-07-31 $-1
2011-04-30 $-1
2011-01-31 $0
2010-10-31 $0
2010-07-31 $0
2010-04-30 $-3
2010-01-31 $-2
2009-10-31 $0
2009-04-30 $-4
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.000B
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.342B 30.89
Zoetis (ZTS) United States $69.034B 25.76
Takeda Pharmaceutical (TAK) Japan $47.411B 9.43
Daiichi Sankyo, - (DSNKY) Japan $44.972B 23.05
BeOne Medicines - (ONC) Cayman Islands $27.694B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.360B 0.00
Merck (MKKGY) Germany $16.226B 11.89
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.581B 14.61
United Therapeutics (UTHR) United States $13.159B 11.64
Neurocrine Biosciences (NBIX) United States $12.599B 43.16
Orion OYJ (ORINY) Finland $10.006B 27.06
IPSEN (IPSEY) France $9.836B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.193B 43.98
Madrigal Pharmaceuticals (MDGL) United States $6.277B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ionis Pharmaceuticals (IONS) United States $5.890B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.000B 0.00
Hypermarcas (HYPMY) Brazil $3.132B 20.60
Crinetics Pharmaceuticals (CRNX) United States $2.856B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.782B 9.75
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.489B 13.46
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.077B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.043B 0.00
Indivior (INDV) United States $1.917B 8.13
Centessa Pharmaceuticals (CNTA) United Kingdom $1.693B 0.00
Endo (NDOI) United States $1.618B 0.00
ARS Pharmaceuticals (SPRY) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.225B 0.00
Harrow (HROW) United States $1.156B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.070B 21.41
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Verve Therapeutics (VERV) United States $0.991B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.902B 0.00
Ardelyx (ARDX) United States $0.864B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
Elite Pharmaceuticals (ELTP) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Xencor (XNCR) United States $0.595B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.32
Altimmune (ALT) United States $0.550B 0.00
Theravance Biopharma (TBPH) United States $0.531B 0.00
Bioventus (BVS) United States $0.528B 13.40
AleAnna (ANNA) United States $0.520B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.459B 9.58
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.432B 0.00
Organogenesis (ORGO) United States $0.415B 0.00
Savara (SVRA) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Liminatus Pharma (LIMN) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.218B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
ProKidney (PROK) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Nanobiotix S.A (NBTX) France $0.202B 0.00
OmniAb (OABI) United States $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Larimar Therapeutics (LRMR) United States $0.175B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Journey Medical (DERM) United States $0.148B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
VAXART, INC (VXRT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.116B 19.09
Protara Therapeutics (TARA) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Dominari Holdings (DOMH) United States $0.092B 0.00
Wellgistics Health (WGRX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.56
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00